At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
TCS IN THE NEWS
You have these already downloaded
We have sent you a copy of the report to your email again.
By SriJyothsna Yeleswarapu, Aditya Rao, Thomas Joseph, Vangala Govindakrishnan Saipradeep and Rajgopal Srinivasan, TCS
A research paper by TCS experts titled "A pipeline to extract drug-adverse event pairs from multiple data sources" was published in the reputed industry journal BMC Medical Informatics and Decision Making.
Pharmacovigilance aims to uncover and understand harmful side-effects of drugs, termed adverse events (AEs). Although the current process of pharmacovigilance is very systematic, the increasing amount of information available in specialized health-related websites as well as the exponential growth in medical literature presents a unique opportunity to supplement traditional adverse event gathering mechanisms with new-age ones.
The paper presents a semi-automated pipeline to extract associations between drugs and side effects from traditional structured adverse event databases as well as from non-traditional sources such as text from MEDLINE abstracts .
Read the complete paper here.